"

According to the latest report published by Data Bridge Market Research, the Buccal Drug Delivery Market

Data Bridge Market Research analyses a growth rate in the buccal drug delivery market in the forecast period 2023-2030. The expected CAGR of buccal drug delivery market is tend to be around 9.8% in the mentioned forecast period. The market value is USD 3.38 billion in 2022, and it would grow upto USD 7.13 billion by 2030.

The large scale Buccal Drug Delivery Market report comprises of historic data along with future forecast and detailed market analysis on a global, local and regional level for Buccal Drug Delivery Market industry. The report helps out in mapping brand awareness, market landscape, possible future issues, industry trends and customer behaviour about Buccal Drug Delivery Market industry which finally results into highly developed business strategies. Global Buccal Drug Delivery Market research report displays a complete overview of the market, including myriad of aspects such as product definition, segmentation based on various parameters, and the existing vendor landscape.

Stay informed with our latest keyword market research covering strategies, innovations, and forecasts. Download full report: https://www.databridgemarketresearch.com/reports/global-buccal-drug-delivery-market

Buccal Drug Delivery Market Segmentation and Market Companies

Segments

- Based on product type, the global buccal drug delivery market is segmented into tablets, sprays, films, and lozenges. The tablets segment is expected to dominate the market due to the ease of administration and a wide range of drugs that can be formulated into tablet form for buccal delivery. The films segment is also projected to witness significant growth owing to their rapid disintegration and high drug absorption rates.

- On the basis of application, the market is categorized into pain management, hormone replacement therapy, smoking cessation, and others. The pain management segment is anticipated to hold a major market share as buccal drug delivery offers quick relief and avoids first-pass metabolism. The hormone replacement therapy segment is also likely to grow steadily due to the convenience and effectiveness of buccal drug delivery for hormone administration.

- By end-user, the global buccal drug delivery market is segmented into hospitals, ambulatory surgical centers, and home care settings. The hospital segment is expected to be the largest revenue-generating segment due to the high patient footfall and the availability of skilled healthcare professionals. The home care settings segment is projected to witness significant growth with the increasing trend towards self-administration of medications.

Market Players

- Some of the key players operating in the global buccal drug delivery market are Cynapsus Therapeutics, Inc., BioDelivery Sciences International, Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., and 3M. These companies are focusing on strategic partnerships, acquisitions, and product launches to strengthen their market presence and expand their product portfolios in the buccal drug delivery space.

- Other notable market players include IntelGenx Corp, Zyomyx, Inc., Camurus AB, Onxeo, and MonoSol Rx. These players are actively engaged in research and development activities to introduce innovative buccal drug delivery technologies and enhance the efficacy of drug delivery systems for better patient outcomes.

The global buccal drug delivery market is witnessing significant growth and is poised for further expansion in the coming years. One key trend driving this market is the increasing preference for alternative drug delivery methods that offer superior efficacy and patient convenience. Buccal drug delivery is gaining traction due to its ability to provide quick drug absorption, bypass the first-pass metabolism, and improve the overall therapeutic outcomes for patients. Moreover, the ease of administration and the versatility of formulations available in buccal delivery forms such as tablets, sprays, films, and lozenges are contributing to the market's growth.

In terms of product type segmentation, tablets are expected to continue dominating the market due to their ease of use and the wide range of drugs that can be incorporated into tablet formulations for buccal delivery. Additionally, the films segment is projected to experience substantial growth owing to their fast disintegration properties and high drug absorption rates, making them a preferred choice for patients seeking quick relief.

From an application perspective, the pain management segment is anticipated to hold a significant market share, driven by the rapid relief provided by buccal drug delivery and its ability to avoid first-pass metabolism. The hormone replacement therapy segment is also expected to witness steady growth due to the convenience and effectiveness of buccal drug delivery for hormone administration, offering patients a non-invasive alternative to traditional delivery methods.

In terms of end-users, hospitals are projected to continue being the largest revenue-generating segment in the global buccal drug delivery market, given the high patient volume and the presence of skilled healthcare professionals in hospital settings. However, the home care settings segment is forecasted to experience notable growth as the trend towards self-administration of medications increases, highlighting the demand for convenient drug delivery methods that can be easily administered at home.

Key players in the global buccal drug delivery market are actively engaged in strategic initiatives such as partnerships, acquisitions, and new product launches to strengthen their market presence and expand their product portfolios. Companies like Cynapsus Therapeutics, Inc., BioDelivery Sciences International, Inc., and Novartis AG are leading the market with a focus on innovation and technological advancements in buccal drug delivery systems. Other notable players such as IntelGenx Corp, Zyomyx, Inc., and Camurus AB are also investing in research and development activities to introduce groundbreaking buccal drug delivery technologies that enhance drug efficacy and improve patient outcomes. Overall, the global buccal drug delivery market presents lucrative opportunities for growth and innovation in the pharmaceutical industry.The global buccal drug delivery market is experiencing robust growth driven by the rising demand for alternative drug delivery methods that offer enhanced efficacy and patient convenience. Buccal drug delivery has gained traction due to its ability to facilitate quick drug absorption, bypass first-pass metabolism, and improve therapeutic outcomes for patients. The market segmentation based on product type highlights the dominance of tablets and the growth potential of films due to their rapid disintegration and high drug absorption rates.

In terms of applications, the pain management segment is expected to hold a significant market share, driven by the immediate relief offered by buccal drug delivery and its ability to avoid first-pass metabolism. Similarly, the hormone replacement therapy segment is poised for steady growth owing to the convenience and effectiveness of buccal drug delivery for hormone administration, presenting a non-invasive option for patients. As for end-users, hospitals are likely to remain the primary revenue generators in the buccal drug delivery market due to their high patient traffic and healthcare expertise. However, the home care settings segment is anticipated to witness notable growth as self-administration of medications becomes increasingly prevalent, emphasizing the demand for convenient drug delivery solutions for home use.

Key players in the market are actively engaging in strategic initiatives such as partnerships, acquisitions, and new product launches to fortify their market presence and broaden their product portfolios. Companies like Cynapsus Therapeutics, Inc., BioDelivery Sciences International, Inc., and Novartis AG are at the forefront of innovation and technological advancements in buccal drug delivery systems. Other noteworthy players such as IntelGenx Corp, Zyomyx, Inc., and Camurus AB are focusing on research and development endeavors to introduce innovative buccal drug delivery technologies that enhance drug efficacy and improve patient outcomes. The global buccal drug delivery market offers promising opportunities for growth and innovation in the pharmaceutical sector, presenting a fertile ground for advancements in drug delivery technology.

Frequently Asked Questions About This Report

How are tiered supplier networks managed in the Buccal Drug Delivery Market industry?
What is the role of automation in Buccal Drug Delivery Market production/delivery?
How does the Premiumization trend affect Buccal Drug Delivery Market consumer choices?
How do regulatory frameworks differ across regions in the Buccal Drug Delivery Market?
What is the impact of e-procurement on Buccal Drug Delivery Market efficiency?
What is the role of third-party logistics (3PL) in the Buccal Drug Delivery Market?
How will the Buccal Drug Delivery Market look after the Fourth Industrial Revolution?
What is the valuation of Buccal Drug Delivery Market in the Renewable Energy market?
Which South American countries offer the best opportunities for Buccal Drug Delivery Market expansion?
How much is the Services segment projected to be worth in 2026?
How is the Buccal Drug Delivery Market responding to the Zero-Waste driver?
How is the Buccal Drug Delivery Market contributing to the UN Sustainable Development Goals?
Which countries are the major contributors to the Buccal Drug Delivery Market in LAMEA?

Browse More Reports:

 Global Electronic Medical Records (EMR) Market
 Global Exterior Insulation Market
 Global Turmeric Supplements Market
 Global Hydrogenated Oils Market
 Global Biofortification Market
 Global Premium Motorcycle Helmets Market
 Global Relational Database Market
 Global Transarterial Chemoembolization (TACE) Market
 Global Automotive Wrap Films Market
 Global Car Mat Market
 Global Direct Current (DC) Circuit Breaker Market
 Global Povidone Iodine Market
 Global Testing Inspection and Certification Market
 Global 1, 3 Butadiene Market
 Asia-Pacific Distributed Antenna System (DAS) Market

Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 976
Email:- corporatesales@databridgemarketresearch.com"